API
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [HEALTH]

2 clusters · 2 sources · 25 days · First seen · Last updated

Autoimmune disease immunotherapy research

Overview

Medical research is transitioning toward therapies that aim to reprogram or reset the immune system rather than providing continuous suppression of inflammation. In multiple sclerosis research, the focus is shifting toward immune reconstitution therapies, such as alemtuzumab and hematopoietic stem cell transplantation, which seek a durable immune reset through lymphocyte depletion and qualitative repopulation.

Further developments include experimental methods for treating severe conditions like rheumatoid arthritis and lupus. These approaches, such as CAR-T therapy adapted from oncology, aim to address underlying causes by reprogramming malfunctioning immune systems. Due to the experimental nature and potential side effects of these treatments, they are currently primarily limited to patients who have exhausted all other known treatment options.

Entities

Johns Hopkins University · NYU Langone Health · Mileydy Gonzalez · Maximilian Konig · Thomas Jefferson University

Timeline

  1. [HEALTH] 2 sources
    Scientists test immune system reprogramming for autoimmune diseases

    Scientists are testing experimental immune system reprogramming to treat autoimmune diseases like lupus and multiple sclerosis, aiming to fix the underlying cause rather than just suppressing symptoms.

  2. [HEALTH] 2 sources
    Multiple sclerosis research shifts toward immune reconstitution therapies

    New research explores shifting multiple sclerosis treatment from continuous immunosuppression toward immune reconstitution therapies that aim for a durable immune reset and antigen-specific tolerance.

Sources

ceskenoviny.cz · topky.sk